Aplicación YC de Equator Therapeutics

Winter 2020Active

Equator Therapeutics pasó por Y Combinator en el batch Winter 2020 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.

Batch YC: Winter 2020
Industria: HealthcareTherapeutics
Tamaño del equipo: 2
Estado: Active
Lanzado: 2020

Fundadores

Liliya KhasinFounder
Yuriy KirichokFounder
Jonah SinickFounder

Lo que hace Equator Therapeutics

We are developing a drug to increase metabolism and burn calories without exercise. Obesity and type 2 diabetes have reached epidemic proportions. There are 2.2B overweight people and 500M people with type 2 diabetes worldwide, and these numbers increase drastically every year. Existing drugs are not effective enough to reverse the trend. Our drug can solve this problem, because it addresses the root cause of metabolic disorders - the imbalance between caloric intake and expenditure. Our drug will target mitochondria - the powerhouse of the cell - to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.

Aplicación YC de Equator Therapeutics, reconstruida

Solicitud de Y Combinator

Equator Therapeutics, batch Winter 2020. Las preguntas reales del formulario, respondidas con datos públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Equator Therapeutics

Describe what your company does in 50 characters or less.

Drug to burn calories and increase metabolism

What is your company going to make? Please describe your product and what it does or will do.

We are developing a drug that activates a natural protein in mitochondria to generate heat, burning calories and increasing metabolism without exercise. Our approach targets the root cause of obesity and type 2 diabetes by shifting the balance between calorie intake and expenditure through mitochondrial heat production, overcoming the side effects of previous methods.

Where do you live now, and where would the company be based after YC?

We live in San Francisco and plan to keep the company based here after YC.

Explain your decision regarding location.

San Francisco is where the team already lives and works, giving us access to biotech talent and resources critical for developing a therapeutic drug.

21 respuestas más en la aplicación completa

están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.

Ver aplicación completa

Preguntas Frecuentes

¿Es esta la aplicación YC real de Equator Therapeutics?

No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Equator Therapeutics (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Equator Therapeutics se presentaría a YC, no el texto que enviaron.

¿En qué batch de YC estuvo Equator Therapeutics?

Equator Therapeutics formó parte del batch Winter 2020 de Y Combinator.

¿Quién fundó Equator Therapeutics?

Equator Therapeutics fue fundado por Liliya Khasin, Yuriy Kirichok, Jonah Sinick.

¿A qué se dedica Equator Therapeutics?

We are developing a drug to burn calories and increase metabolism…

¿Cómo leo la aplicación completa reconstruida?

Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Equator Therapeutics, y de cada otro batch de YC, está en YC Insights.